Cadila receives USFDA approval to market Tadalafil in US

Zydus Cadila has received final USFDA approval to market Tadalafil tablets in American markets. The drug Tadalafil is used to erectile dysfunction and enlarged prostrate. It will be made available in strengths of 2.5 mg, 5 mg, 10 mg and 20 mg. The drug will be manufactured at its Moraiya, Ahmedabad-based facility.

Company Profile : Cadila Healthcare Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.